ArticleFrontiers in medicine2025

Comparison of the effect of iguratimod and hydroxychloroquine on regulatory B cells in the treatment of primary Sjögren's syndrome.

Jin-Mei Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.